Skip to main content
Clinical Trials/IRCT20110413006186N13
IRCT20110413006186N13
Recruiting
Phase 2

A Comparison of the Effectiveness of Transcutaneous Electrical Nerve Stimulation and Duloxetine on Diabetic Peripheral Neuropathic pain

Rasht University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • patients type I or II diabetes mellitus, with diabetic neuropathic pain
  • Resistant to usual drug treatments, at least for 6 months
  • Minimum Pain Rating 4 based on Numerical Rating
  • Having normal creatinine and CBC blood counts
  • HBA1C less than 8%.

Exclusion Criteria

  • Having a pacemaker or defibrillator
  • Having brain stimulators
  • Infection or inflammation at the site of electrodes
  • Other neuropathies with causes other than diabetes
  • Alcohol consumption history
  • Malignant history
  • Tens Records history
  • Bipolar patients
  • Duloxetine contraindications such as liver or kidney failure and MAO\-I simultaneous use

Outcomes

Primary Outcomes

Not specified

Similar Trials